+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Automated External Defibrillator Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022-2027)

  • PDF Icon

    Report

  • 121 Pages
  • July 2022
  • Region: Global
  • Mordor Intelligence
  • ID: 4774973
The global automated external defibrillator market was valued at USD 717.52 million in 2021, and it is projected to register a CAGR of 9.4% during the forecast period. Automated external defibrillators are life-saving devices that help in the correction of cardiac rhythm. The major factors driving the growth of the automated electronic defibrillator market include the growing prevalence of cardiac diseases, the rising geriatric population, and technological advancements in the field, supported by increasing investments from market players.

Since the start of the pandemic, COVID-19 has affected the global economy in three ways, by directly affecting production and demand, by creating a disruption in the supply chain, and financial impact on firms and financial markets due to strict lockdowns in most countries. Delays in the delivery of products and services have been seen due to countries' newer packaging protocols and lockdown measures. All these factors negatively impacted the manufacturing and supply chain of the defibrillators market. However, it is balanced by the increase in demand due to the surge in cardiovascular patients across all the regions as automated external is an effective intervention for cardiac arrest.

The burden of cardiac diseases is rising with the prevailing sedentary lifestyle in the population and the growing geriatric population around the world. For instance, the Journal of Cardiovascular Development and Disease article titled ‘’Cardiovascular Risks Associated with Gender, and Aging’’, published in April 2019, reported that the aging and elderly populations are particularly susceptible to cardiovascular diseases.

Additionally, it also reported that risk factors closely associated with advanced age, such as frailty, obesity, and diabetes, have been shown to compound risks of cardiovascular disease. Such studies demonstrate that the chances of cardiovascular diseases increase with age.

Furthermore, according to the Australian Government, Australia Institute of Health and Welfare article titled ‘‘Heart, stroke and vascular disease - Australian facts’’, updated in September 2021, reported that in 2019, cardiovascular diseases were the underlying cause of death in Australia and accounted for 42,300 deaths, which are nearly 25% of all deaths in Australia. Such a high burden of deaths generates a need for automated external defibrillators, thus driving the market's growth.

Moreover, the technological advancement in the field and the launch of new products by the market players boost the market's growth. For instance, in July 2020, ZOLL Medical Corporation (Asahi Kasei Group company) launched its new remote view technology on the X Series monitor/defibrillator developed for EMS agencies.

Thus, the automated external defibrillators market is expected to show lucrative growth over the forecast period. However, factors such as stringent regulations and lack of awareness and early corrective measures about Sudden Cardiac Arrest (SAC) may hinder the growth of the studied market over the forecast period.

Key Market Trends


The Rising Prevalence of Cardiac Diseases to Drive the Market


The rising prevalence of cardiac diseases across different age groups due to stressful work conditions, sedentary lifestyle, growing consumption of tobacco and alcohol, and substance abuse is expected to drive the growth of the automated external defibrillator market over the forecast period.

According to the International Journal of Stroke article titled ‘‘Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge’’, published in January 2020, the worldwide prevalence of atrial fibrillation was 37,574 million cases (0.51% of worldwide population), which increased by 33% during the last 20 years. It also reported that future projections suggest that the absolute atrial fibrillation burden may increase by more than 60% in 2050. Such a growing burden of arrhythmia creates demand for the automated external defibrillator and is expected to drive the growth of the studied market over the forecast period.

As per an article published in the Australia Institute of Health and Welfare titled ‘’Heart, stroke and vascular disease - Australian facts’’, updated in September 2021, during 2018-2019, there were 5,91,000 hospitalizations with cardiovascular diseases as principal diagnosis happened in Australia. Such a high number of hospitalization due to cardiovascular diseases generates a need for devices for correct cardiac rhythm. Thus, it is expected to drive the growth of the market.

Furthermore, the increasing number of deaths due to cardiac diseases is also boosting the market's growth. For instance, the World Health Organization (WHO)’s article titled ‘’Cardiovascular diseases (CVDs)’’, published in June 2021, reported that cardiovascular diseases are the leading cause of death globally. Additionally, it reported that an estimated 17.9 million people died from CVDs in 2019, which represented 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke. Such a high number of deaths due to it creates demand for the devices that help in cardiac rhythm corrections, driving the market's growth.

Also, the Journal of Cardiovascular Development and Disease article titled ‘‘Cardiovascular Risks Associated with Gender and Aging’’, published in April 2019, reported that in the American Heart Association (AHA) 2019 Heart Disease and Stroke Statistical Update, the incidence of cardiovascular diseases from age 60-79 years was 77.2% in males and 78.2% in females. Furthermore, the incidence of CVD in adults above 80 years of age was 89.3% in males and 91.8% in females. Such a high prevalence of cardiac disease in older age is driving the market's growth. Thus, owing to the abovementioned factors, the market is expected to project growth over the forecast period.



North America is Expected to Hold a Major Market Share


The US automated external defibrillators market is expected to grow during the forecast period due to the high burden and increasing prevalence of cardiovascular diseases, new product launches, and the emerging number of key market players in the region. For instance, according to the American Heart Association statistics published in January 2019, nearly half of the Americans have some cardiovascular diseases, including hypertension and coronary heart diseases, which is expected to increase the burden of cardiovascular diseases in the country, driving the growth of the studied market.

American Heart Association’s Heart & Stroke Statistics - 2020 Update claimed that over 356,000 out-of-hospital cardiac arrests occur in the United States each year, and nearly 90% of them are fatal. The estimated number of the incidence of out-of-hospital cardiac arrests (OHCA) among adults in the United States was 347,322. Less than half (45.7%) of cardiac arrest victims get immediate help before emergency responders arrive in part because emergency medical services take, on average, between four and ten minutes to reach someone in cardiac arrest. However, if automated external defibrillators (AEDs) are available nearby, this high mortality from out-of-hospital cardiac arrests can be reduced, which may increase the demand for automated external defibrillators (AEDs) in the country, projecting the growth of the market studied.

Further, as per the September 2021 report of the Centers for Disease Control and Prevention, about 659,000 people in the United States die from heart diseases every year, and approximately 805,000 people have a heart attack every year, of which 605,000 experienced their first heart attack, and 200,000 people already had one heart attack. This high prevalence of heart attack is expected to fuel the growth of the market studied in the United States.

The rising prevalence of cardiovascular diseases in Canada, increasing research and development investment, and rising awareness about defibrillators in the country are expected to boost the growth of the automated external defibrillators market over the forecast period. According to the Canadian Centre for Occupational Health and Safety (CCOHS) article published in June 2020, in Canada, more than 40,000 people die of sudden cardiac arrest, which is about one person every 12 minutes, and over 100 people per day. This high number of sudden cardiac arrests in the country leads to high demand for automated external defibrillators (AEDs), which can be crucial in preventing these deaths. Thus, the market is expected to grow over the forecast period.

As per the source mentioned above, many other medical conditions and lifestyles can put people at higher risk of heart diseases, including diabetes, overweight and obesity, unhealthy diet, high alcohol consumption, and physical inactivity.



Competitive Landscape


The automated external defibrillator market is moderately competitive, with the presence of a few major players like Asahi Kasei Corporation, Koninklijke Philips NV, Nihon Kohden Corporation, Shenzhen Mindray Bio-Medical Electronics Co. Ltd, Schiller AG, Stryker Corporation, CU Medical System Inc., Mediana Co. Ltd, BPL Medical Technologies Pvt. Ltd, ViVest Medical, etc. However, with technological advancements and product innovation, the market players are introducing new products with cost-effective pricing.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support


This product will be delivered within 2 business days.

Table of Contents

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY3 EXECUTIVE SUMMARY
4 MARKET INSIGHTS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Prevalence of Cardiovascular Diseases
4.2.2 Technological Advancements in the Field of Defibrillators
4.2.3 Increasing Investments by Private Players
4.3 Market Restraints
4.3.1 Stringent Regulations
4.3.2 Lack of Awareness and Early Corrective Measures about Sudden Cardiac Arrest (SAC)
4.4 Industry Attractiveness - Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 Analysis Type
5.1.1 Semi-automated External Defibrillators
5.1.2 Fully-automated External Defibrillators
5.2 End User
5.2.1 Hospitals/Clinics
5.2.2 Home Care
5.2.3 Other End Users
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Asahi Kasei Corporation
6.1.2 Koninklijke Philips NV
6.1.3 Nihon Kohden Corporation
6.1.4 Schiller AG
6.1.5 Shenzhen Mindray Bio-Medical Electronics Co. Ltd
6.1.6 Stryker Corporation
6.1.7 CU Medical System Inc
6.1.8 Mediana Co. Ltd
6.1.9 BPL Medical Technologies Pvt. Ltd
6.1.10 ViVest Medical
7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Asahi Kasei Corporation
  • Koninklijke Philips NV
  • Nihon Kohden Corporation
  • Schiller AG
  • Shenzhen Mindray Bio-Medical Electronics Co. Ltd
  • Stryker Corporation
  • CU Medical System Inc.
  • Mediana Co. Ltd
  • BPL Medical Technologies Pvt. Ltd
  • ViVest Medical

Methodology

Loading
LOADING...